Axatilimab Demonstrates Effectiveness in Refractory/Recurrent GVHD.

Published Date: 15 Dec 2023

lowest dose produced the least amount of toxicity and the highest overall response rate.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

TRK Inhibitor Active in Treatment-Refractory Glioblastoma

2.

Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease

3.

In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.

4.

Research finds COVID-19 mRNA vaccine sparks immune response to fight cancer

5.

VP Nominee Medical Records Breached; Queen Elizabeth's Cancer; Galaxy Gas Whippets


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot